Big Bull Rakesh Jhunjhunwala Passes Away At Age 62 businessworld.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessworld.in Daily Mail and Mail on Sunday newspapers.
Sirolimus Market Research Report by Application, by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19 benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Lupin launches Mycophenolate Mofetil Tablets USP, 500 mg
Mumbai, Dec 29 (UNI) Pharma major Lupin on Tuesday announced the launch of Mycophenolate Mofetil Tablets USP, 500 mg, after Lupin’s alliance partner Concord Biotech Limited (Concord) received an approval for its ANDA from the United States Food and Drug Administration. Mycophenolate Mofetil Tablets USP, 500 mg, are the generic equivalent of CellCept® Tablets of Roche Palo Alto LLC, indicated for the prophylaxis of organ rejection in recipients of allogeneic kidney, heart or liver transplants, and should be used in combination with other immunosuppressants. Mycophenolate Mofetil Tablets USP had an annual sales of approximately USD 87 million in the U.S. (IQVIA MAT October 2020).